Lyra Therapeutics Future Growth
How is Lyra Therapeutics forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score
2/6Future Growth Score 2/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
9.0%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 12 | -84 | -86 | -74 | 2 |
| 12/31/2024 | N/A | -75 | -75 | -71 | 2 |
| 12/31/2023 | 0 | -63 | -68 | -62 | 4 |
| 9/30/2022 | 2 | -55 | -44 | -43 | N/A |
| 6/30/2022 | 1 | -51 | -44 | -42 | N/A |
| 3/31/2022 | 1 | -48 | -32 | -30 | N/A |
| 12/31/2021 | 0 | -44 | -29 | -26 | N/A |
| 9/30/2021 | 0 | -37 | -24 | -20 | N/A |
| 6/30/2021 | N/A | -32 | -17 | -14 | N/A |
| 3/31/2021 | N/A | -26 | -28 | -25 | N/A |
| 12/31/2020 | N/A | -22 | -23 | -21 | N/A |
| 9/30/2020 | N/A | -20 | -20 | -19 | N/A |
| 6/30/2020 | N/A | -18 | -19 | -19 | N/A |
| 3/31/2020 | N/A | -17 | -15 | -15 | N/A |
| 12/31/2019 | N/A | -17 | -14 | -14 | N/A |
| 12/31/2018 | 1 | -6 | -7 | -7 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LYRA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: LYRA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: LYRA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: LYRA's revenue (71% per year) is forecast to grow faster than the US market (6.9% per year).
High Growth Revenue: LYRA's revenue (71% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LYRA's Return on Equity is forecast to be high in 3 years time